Unosi
-
In Silico and In Vitro Studies of Alchemilla viridiflora Rothm—Polyphenols’ Potential for Inhibition of SARS-CoV-2 Internalization (2022-08)
R. Suručić, J. Radović Selgrad, T. Kundaković-Vasović, B. Lazović, M. Travar, LJ. Suručić, R. Škrbić, In Silico and In Vitro Studies of Alchemilla viridiflora Rothm—Polyphenols’ Potential for Inhibition of SARS-CoV-2 Internalization, MOLECULES: A JOURNAL OF SYNTHETIC ORGANIC AND NATURAL PRODUCT CHEMISTRY, Vol. 27, No. 16, Aug, 2022 -
Batch sorption dynamics and equilibrium for the capture of Ni(II) onto activated carbon developed from yellow dock (Rumex crispus) (2024-10)
M. Momčilović, M. Radović Vučić, S. Meseldžija, N. Velinov, LJ. Suručić, A. Bojić, Batch sorption dynamics and equilibrium for the capture of Ni(II) onto activated carbon developed from yellow dock (Rumex crispus), Biomass Conversion and Biorefinery, Oct, 2024 -
Protivizvršenje po prijedlogu trećeg lica i po prijedlogu učesnika (2025-02-17T13:47:55.400Z)
-
Način(i) sticanja prava svojina na stanu u izgradnji u pravu Republike Srpske (2025-02-17T11:56:09.785Z)
-
Načelo tripartizma (2025-02-17T11:49:52.402Z)
-
Deoba zajedničke imovine supružnika (2025-02-17T10:47:51.874Z)
-
Realni tereti u pravu Republike Srpske (2025-02-17T10:30:15.005Z)
-
Oblici neposrednog učešća građana u odlučivanju na lokalnom nivou u Bosni i Hercegovini (2025-02-17T08:45:01.901Z)
-
Zadržavanje duševno bolesnog lica u zdravstvenoj ustanovi (2025-02-17T08:30:11.908Z)
-
Kompozitorski konkurs Vlado S. Milošević, četvrta muzička emisija emitovana na Radiju Republike Srpske 17. 02. 2025. god. (2025)
B. Smailagić, Kompozitorski konkurs Vlado S. Milošević, četvrta muzička emisija emitovana na Radiju Republike Srpske 17. 02. 2025. god., Radio Republike Srpske, 2025 -
Facsimile Reconstruction of Villa Bozic with the Application of Energy Efficiency Measures (2011-04)
S. Cvijić, M. Kotur, T. Glamočić, Facsimile Reconstruction of Villa Bozic with the Application of Energy Efficiency Measures, Energy Efficiency and Energy Management in Cultural Heritage, pp. 115 - 115, Apr, 2011 -
Odgovor na terapiju Rituximabom kod pacijenata sa reumatoidnim artritisom (2010-09)
LJ. Božić, Odgovor na terapiju Rituximabom kod pacijenata sa reumatoidnim artritisom, ACTA RHEUMATOLOGICA BELGRADENSIA, Sep, 2010 -
Prikaz slučaja: '' Vilonodularni sinovitis zgloba kuka'' (2012-09)
LJ. Božić, Prikaz slučaja: '' Vilonodularni sinovitis zgloba kuka'', ACTA RHEUMATOLOGICA BELGRADENSIA, Sep, 2012 -
Prikaz slučaja: Prikaz slučaja pacijentice sa sistemskim eritemskim lupusom I dijabetes melitusom tip 1’’ (2013-03)
LJ. Božić, Prikaz slučaja: Prikaz slučaja pacijentice sa sistemskim eritemskim lupusom I dijabetes melitusom tip 1’’, ACTA RHEUMATOLOGICA BELGRADENSIA, Mar, 2013 -
Prikaz slučaja: '' Sekundarna hipertrofična osteoartropatija'' (2013-06)
LJ. Božić, Prikaz slučaja: '' Sekundarna hipertrofična osteoartropatija'', INTERNIST, Jun, 2013 -
Pharmacokinetics and Safety of Three Formulations of Rituximab (CT-P10, US-sourced Innovator Rituximab and EU-sourced Innovator Rituximab) in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks (2016-09)
LJ. Božić, Pharmacokinetics and Safety of Three Formulations of Rituximab (CT-P10, US-sourced Innovator Rituximab and EU-sourced Innovator Rituximab) in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks, STED Journal, Sep, 2016 -
Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks (2016-09)
LJ. Božić, Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks, STED Journal, Sep, 2016 -
Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial (2018-08)
LJ. Božić, Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial, STED Journal, Aug, 2018 -
The importance of renal impairment in systemic sclerosis (2023-06)
LJ. Božić, The importance of renal impairment in systemic sclerosis, ANNALS OF THE RHEUMATIC DISEASES, Jun, 2023 -
The effect of socio-demographic characteristics on the burnout syndrome of nurses in Republic of Srpska during the COVID-19 pandemic (2024-09)
LJ. Božić, The effect of socio-demographic characteristics on the burnout syndrome of nurses in Republic of Srpska during the COVID-19 pandemic, Scripta Medica, Sep, 2024